SEC Form 4 · accession 0001127602-15-003848
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph G Darling
Officer — EVP, Commercial Operations
Period of report
Feb 2, 2015
Accepted (ET)
Feb 3, 2015 · 11:38 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2015 | M | 10,000 | $26.69 | A | 22,015 | D | |
| Common Stock | Feb 2, 2015 | F | 6,893 | $47.85 | D | 15,122 | D | |
| Common Stock | Feb 2, 2015 | M | 4,000 | $26.09 | A | 19,122 | D | |
| Common Stock | Feb 2, 2015 | F | 2,722 | $47.85 | D | 16,400 | D | |
| Common Stock | Feb 2, 2015 | M | 2,000 | $32.93 | A | 18,400 | D | |
| Common Stock | Feb 2, 2015 | F | 1,563 | $47.85 | D | 16,837 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F1 | $26.69 | Feb 2, 2015 | M | 10,000 | D | — | Jun 1, 2018 | Common Stock | 10,000 | 0 | D |
| Sars (Stock Appreciation Rights)F2 | $26.09 | Feb 2, 2015 | M | 4,000 | D | — | Jun 1, 2022 | Common Stock | 4,000 | 6,000 | D |
| Sars (Stock Appreciation Rights)F2 | $32.93 | Feb 2, 2015 | M | 2,000 | D | — | Jun 1, 2023 | Common Stock | 2,000 | 8,000 | D |
Explanation of responses
- F1The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
- F2The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.